Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
MYOS RENS Technology Announces Results of Its 2018 Annual Meeting of Stockholders | ||
By: PR Newswire Association LLC. - 13 Dec 2018 | Back to overview list |
|
CEDAR KNOLLS, N.J., Dec. 13, 2018 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announced the results from the Company's Annual Meeting of Stockholders held today. At the meeting, each of the following proposals were approved and adopted:
Eric Zaltas is the founder and Chief Executive Officer of Pivot Nutrition LLC, a startup company focused on researching, developing and distributing products for various brands targeting athletes. Mr. Zaltas was previously Vice President of R&D and Commercialization at Premier Nutrition Corporation, a division of Post Holdings, Inc. from 2014 to 2018 where he led the integration of the R&D teams, pipelines and innovation processes for both the Premier and PowerBar(s) teams. Joseph Mannello, Chief Executive Officer of MYOS, commented, "Eric will be a strong addition to our board of directors, bringing incomparable expertise and diverse R&D and commercial experience. He is the perfect fit for MYOS and we're fortunate to have him join our board at this critical time." Mr. Zaltas holds a B.S. degree in Geophysics from the State University of New York at Stony Brook and a M.S. degree in Human Nutrition from the University of New Haven. He also received a Diploma in Sports Nutrition from the International Olympic Committee based in Lausanne, Switzerland. "I'm excited to be a part of the MYOS team at such a pivotal time, following the successful launch of MYOS Canine Muscle Formula, and as the company launches its compelling sports nutrition brand, Yolked®, which is currently making great strides on college campuses," said Mr. Zaltas. About MYOS RENS Technology Inc. Forward-Looking Statements These statements have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure or prevent any disease. Investor Relations:
View original content to download multimedia:http://www.prnewswire.com/news-releases/myos-rens-technology-announces-results-of-its-2018-annual-meeting-of-stockholders-300765363.html SOURCE MYOS RENS Technology |
||
|
||
Copyright 2018 PR Newswire Association LLC. | Back to overview list |